Adverum Biotechnologies Inc Stock
Adverum Biotechnologies Inc Stock price
Key metrics
| Market capitalization | $150.39m |
| Enterprise Value | $50.45m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 0.90 |
| Revenue growth (TTM) Revenue growth | -100.00% |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-117.71m |
| Free Cash Flow (TTM) Free Cash Flow | $-89.54m |
Is Adverum Biotechnologies Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.
Adverum Biotechnologies Inc Stock Analysis
Analyst Opinions
8 Analysts have issued a Adverum Biotechnologies Inc forecast:
Analyst Opinions
8 Analysts have issued a Adverum Biotechnologies Inc forecast:
Financial data from Adverum Biotechnologies Inc
| Jun '24 |
+/-
%
|
||
| Net Profit | -100 -100 |
25%
25%
|
|
| Depreciation and Amortization | 4.47 4.47 |
67%
67%
|
|
| Stock Compensation | 17 17 |
11%
11%
|
|
| Operating Cash Flow | -89 -89 |
11%
11%
|
|
| Investments | 0.79 0.79 |
30%
30%
|
|
| Dividend Paid | - - |
-
|
|
| Free Cash Flow | -90 -90 |
11%
11%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Adverum Biotechnologies Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Adverum Biotechnologies Inc Stock News
Company Profile
Adverum Biotechnologies, Inc. is a clinical-stage biotechnology company that engages in the development of novel gene therapies to treat patients with sight-threatening ophthalmic diseases. It focuses on treatment of wet age-related macular degeneration, alpha-1 antitrypsin deficiency, hereditary angioedema, friedreich's ataxia, severe allergy, color vision deficiency, and juvenile x-linked retinoschisis. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Menlo Park, CA.
| Head office | United States |
| CEO | Laurent Fischer |
| Employees | 121 |
| Founded | 2006 |
| Website | www.adverum.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
